DIA391.36-5.21 -1.31%
SPX5,282.70+7.00 0.13%
IXIC16,286.45-20.71 -0.13%

What to Expect From IDEX’s Next Quarterly Earnings Report

Barchart·04/08/2025 04:26:51
Listen to the news

With a market cap of $12.3 billion, IDEX Corporation (IEX) provides applied solutions worldwide. Founded in 1987, the Northbrook, Illinois-based company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The company is expected to announce its fiscal Q1 earnings results on Tuesday, Apr. 22.

Ahead of this event, analysts project the company to report a profit of $1.64 per share, down 12.8% from $1.88 per share in the year-ago quarter. The company has beaten Wall Street's EPS estimates in all of the last four quarters, which is impressive. In the fourth quarter, IEX reported EPS of $2.04, surpassing consensus estimates marginally.

For fiscal 2025, analysts expect IEX to report an EPS of $8.21 per share, up 4.1% from $7.89 in fiscal 2024. Moreover, its EPS is expected to increase 11.1% year-over-year to $9.12 per share in fiscal 2026.

www.barchart.com

Shares of IEX have declined 31.9% over the past 52 weeks, underperforming the S&P 500 Index’s ($SPX2.7% fall and the Industrial Select Sector SPDR Fund’s (XLI6.6% decline over the same time frame.

www.barchart.com

IEX stock declined marginally after the release of its Q4 results on Feb. 4. The company reported a robust 9.4% year-over-year growth in net sales, which amounted to $862.9 million. Additionally, delivered an 11.6% year-over-year growth in adjusted net income, which amounted to $155.1 million. For the current year, the company expects its full-year organic sales to grow by a modest 1% to 3%.

Analysts' consensus view on IEX’s stock is moderately bullish, with a "Moderate Buy" rating overall. Among 11 analysts covering the stock, six recommend a "Strong Buy," one recommends a “Moderate Buy,” and the remaining four indicate a “Hold” rating.

Its average analyst price target of $234.10 indicates a premium of 43.7% from the current market prices.


On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.